abstract |
The present invention relates to the use of recombinant silicatein-β or silicatein-β isolated from natural sources as well as to silicatein-β-fusion proteins as well as silicatein-β-related enzymes for the synthesis, the degradation and for modification of silicon dioxide (condensation products of silicic acid, silicates), silicones and other silicon(IV)- or metal(IV)-compounds, and their technical uses. |